My preferred news would be a combined ph 2/3 trial of BIT225 combined with Lovastatin or another net inhibitor, and ART, with the objective of providing a cure for HIV. Also that discussions are occurring with both Gilead and GSK to determine who will fund and partner in the 6 month ;-) trial.
But I might be dreaming.
Ann: Pause in Trading, page-198
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $19.85M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $5.848K | 265.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1098181 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 97130 | 1 |
View Market Depth
| Last trade - 15.32pm 17/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |